MId-Day Losers From December 4: Kindred Biosciences, Barnes & Noble, Aeropostale

By: via Benzinga
Kindred Biosciences Inc (NASDAQ: KIN) -30% - Late Wednesday the company announced plans to stop its Atokin Study. Following the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.